Broker Recommendations
Investors expect European share rally to continue - BofA
Investors increasingly expect the European equity rally to continue into 2022 but for gains to be more muted, a Bank of America survey showed.
Liberum cautious on durability of Covid boost for Dechra Pharmaceuticals
Analysts at Liberum hiked their target price for shares of Dechra Pharmaceuticals but kept their recommendation at 'sell', telling clients that they struggled to justify such a lofty valuation.
Morgan Stanley downgrades US equities to 'underweight', says growth pessimism excessive
Equity strategists at Morgan Stanley downgraded their recommendation for US stocks ahead of the final stages of what they termed a mid-cycle transition.
Numis upgrades BT Group but says shares overvalued
Analysts at Numis upgraded their recommendation on shares of BT Group from 'sell' to 'reduce' after the share price moved to just 14% above their 140. 0p target price.
ShoreCap reiterates 'buy' on Tesco in anticipation of 'strong' first half numbers
Analysts at ShoreCap reiterated their 'buy' recommendation on Tesco shares, telling clients they anticipated "strong" first half numbers.
Liberum hikes target for Alpha FX, says estimates 'conservative'
Analysts at Liberum hiked their target price on shares of Alpha FX after the currency management specialist reported a more than tripling in profits at the half-year stage.
JP Morgan sees stocks climbing 'wall of worry'
Equity strategists at JP Morgan remained positive on the future direction of stock markets, telling clients that they were set to continue climbing the proverbial 'wall of worry'.
Credit Suisse says DS Smith trading at undeserved premium to peers
Credit Suisse bumped up its target price for shares of DS Smith from 470. 0p to 500. 0p, as demand continued to surprise to the upside.
JP Morgan constructive on equities but expects cyclicals to lead into year-end
Equity strategists at JP Morgan remained "constructive" on equities, but predicted that leadership in the stock market would shift towards cyclicals going into year-end.
Jefferies stays at 'buy' on Anglo American despite headwinds from Chinese housing
Analysts at Jefferies reiterated their 'buy' recommendation for shares of Anglo American following investor meetings with the miner's boss, Mark Cutifani, its finance director, Stephen Pearce, and its head of investor relations, Paul Galloway.
ShoreCap resumes coverage on Beazley at 'buy' on rate momentum and valuation grounds
Analysts at ShoreCap resumed coverage of Beazley with a 'buy' recommendation, arguing that the insurer was "best placed" to benefit from the rating cycle across its cyber and liability (casualty) lines - where rate momentum was accelerating.
Canaccord raises target price on Kainos
Analysts at Canaccord Genuity hiked their target price on software firm Kainos from 1,515. 0p to 1,765. 0p on Wednesday, stating margin normalisation now looked set to begin.
Berenberg raises target price on AstraZeneca
Analysts at Berenberg raised their target price on drugmaker AstraZeneca from 9,500. 0p to 10,000. 0p on Thursday following the firm's second-quarter earnings results.
JPMorgan lowers target price on Asos
Analysts at JPMorgan lowered their target price on online clothing retailer Asos from 6,800. 0p to 6,680. 0p on Friday following its full-year 2021 results preview.
Berenberg lowers target price on Asos ahead of CMD
Analysts at Berenberg lowered their target price on online clothing retailer Asos from 6,700. 0p to 6,500. 0p on Monday ahead of the firm's capital markets day next month.
Berenberg slightly lowers target price on Ashmore Group
Analysts at Berenberg slightly lowered their target price on investment manager Ashmore Group from 340. 0p to 330. 0p on Friday, stating margin pressures were now compounding net flow risks.
Berenberg cuts target price on EasyJet after larger-than-expected equity raise
Analysts at Berenberg cut their target price on low-cost carrier EasyJet from 930. 0p to 720. 0p on Monday after the group's larger than expected equity raise.
Berenberg raises target price on Darktrace
Analysts at Berenberg raised their target price on software outfit Darktrace from 750. 0p to 850. 0p on Wednesday, citing outperformance "across the board".
Berenberg upgrades IHG to 'buy'
Analysts at Berenberg upgraded Holiday Inn owner Intercontinental Hotels Group from 'hold' to 'buy' on Friday following a better-than-expected first-half performance.
Berenberg downgrades 'big fella' BHP from 'buy' to 'hold'
Analysts at Berenberg downgraded mining giant BHP from 'buy' to 'hold' on Monday, stating "the big fella" was lacking near-term catalysts.